六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000446 Act: 33 Size: 1 KB 网页链接
$Aytu BioScience(AYTU)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001213900-20-005050 Act: 33 Size: 217 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001213900-20-004842 Act: 34 Size: 43 KB 网页链接
$Aytu BioScience(AYTU)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001213900-20-004645 Act: 33 Size: 732 KB 网页链接
$Aytu BioScience(AYTU)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-20-004639 Act: 33 Size: 753 KB 网页链接
$Aytu BioScience(AYTU)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001213900-20-004510 Act: 33 Size: 1 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 3.01 Accession Number: 0001213900-20-004505 Act: 34 Size: 19 KB 网页链接
$Aytu BioScience(AYTU)$ PRE 14A Other preliminary proxy statements Accession Number: 0001213900-20-004502 Act: 34 Size: 372 KB 网页链接
$Aytu BioScience(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000919574-20-001773 Act: 34 Size: 320 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000919574-20-001733 Size: 42 KB 网页链接